dual topoisomerase II inhibitors (Angelini Pharmaceuticals)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedual topoisomerase II inhibitors (Angelini Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAntimicrobial multidrug resistance inhibitors
TargetsUpdating
Therapy Area/IndicationsEnterococcus faecium infectionsEnterococcus Faecalis InfectionsAcinetobacter Baumannii Infections +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAngelini Pharma SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAngelini Pharma SPA
Active IndicationsN/A
Inactive IndicationsEnterococcus faecium infectionsEnterococcus Faecalis InfectionsAcinetobacter Baumannii Infections +[6] 

Other Information

ATC CodeN/A
Related LinksN/A